Chemomab Therapeutics Ltd.
CMMB
$1.74
-$0.03-1.70%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.37M | 9.37M | 14.27M | 19.38M | 32.71M |
| Total Receivables | 195.00K | 1.10M | 263.00K | 439.00K | 995.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.86M | -- | 1.44M | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 148.00K | 76.00K | 75.00K | 77.00K |
| Total Current Assets | 13.43M | 10.61M | 16.04M | 19.89M | 33.78M |
|
|
|||||
| Total Current Assets | 13.43M | 10.61M | 16.04M | 19.89M | 33.78M |
| Net Property, Plant & Equipment | 176.00K | 217.00K | 539.00K | 577.00K | 545.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 211.00K | 298.00K | 385.00K | 428.00K | 690.00K |
| Total Assets | 13.81M | 11.13M | 16.96M | 20.90M | 35.01M |
|
|
|||||
| Total Accounts Payable | 485.00K | 378.00K | 633.00K | 386.00K | 2.22M |
| Total Accrued Expenses | 993.00K | 1.05M | 2.47M | 3.85M | 4.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 115.00K | 112.00K | 115.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.48M | 1.43M | 3.22M | 4.35M | 7.00M |
|
|
|||||
| Total Current Liabilities | 1.48M | 1.43M | 3.22M | 4.35M | 7.00M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 209.00K | 230.00K | 62.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.48M | 1.43M | 3.43M | 4.58M | 7.06M |
|
|
|||||
| Common Stock & APIC | 123.95M | 117.70M | 116.16M | 115.98M | 101.74M |
| Retained Earnings | -111.62M | -108.00M | -102.62M | -99.66M | -72.57M |
| Treasury Stock & Other | -- | -- | -- | -- | -1.22M |
| Total Common Equity | 12.33M | 9.70M | 13.54M | 16.32M | 27.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.33M | 9.70M | 13.54M | 16.32M | 27.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.33M | 9.70M | 13.54M | 16.32M | 27.95M |
|
|
|||||